Veru (VERU) Cash & Equivalents (2010 - 2026)
Veru's Cash & Equivalents was $23.88 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 59.1% from $15.01 million a year earlier but down 13.5% from the prior quarter.
Powered by 
Analysis
Veru (VERU) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Cash & Equivalents at Veru came in at $15.79 million, down 36.6% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 3.1% (FY2020 to FY2025).
- In earlier fiscal years, Cash & Equivalents was $24.92 million in FY2024 (+158.9%), $9.63 million in FY2023 (-88.0%), $80.19 million in FY2022 (-34.5%) and $122.36 million in FY2021 (+800.4%).
- Quarterly Cash & Equivalents has moved between $9.63 million (fiscal Q4 2023) and $122.36 million (fiscal Q4 2021) over five years.
- Compared with a year earlier, Cash & Equivalents has increased for three straight quarters, with growth averaging 14.7% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was fiscal Q4 2021 (growth of 800.4%); the worst was fiscal Q4 2023 (a decline of 88.0%).
- Per Business Quant data, VERU's Cash & Equivalents in the three fiscal quarters before Q3 2026 was $27.6 million (Q2 2026), $32.99 million (Q1 2026) and $15.79 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Veru | 57.86 Mn | -52.42 Mn | - | 23.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.88 Mn |
| Mar 31, 2026 | 27.60 Mn |
| Dec 31, 2025 | 32.99 Mn |
| Sep 30, 2025 | 15.79 Mn |
| Jun 30, 2025 | 15.01 Mn |
| Mar 31, 2025 | 20.02 Mn |
| Dec 31, 2024 | 26.61 Mn |
| Sep 30, 2024 | 24.92 Mn |
| Jun 30, 2024 | 29.15 Mn |
| Mar 31, 2024 | 34.74 Mn |
| Dec 31, 2023 | 40.58 Mn |
| Sep 30, 2023 | 9.63 Mn |
| Jun 30, 2023 | 16.21 Mn |
| Mar 31, 2023 | 23.50 Mn |
| Dec 31, 2022 | 46.93 Mn |
| Sep 30, 2022 | 80.19 Mn |
| Jun 30, 2022 | 100.55 Mn |
| Mar 31, 2022 | 112.02 Mn |
| Dec 31, 2021 | 116.10 Mn |
| Sep 30, 2021 | 122.36 Mn |
API Access
Veru Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VERU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();